[
  {
    "ts": null,
    "headline": "Calamos Long/Short Equity & Dynamic Income Trust Q1 2025 Commentary",
    "summary": "For the quarter ending March 31, 2025, Calamos Long/Short Equity & Dynamic Income Trustâs total return was 1.69% on NAV and 6.82% on market price. Read more here.",
    "url": "https://finnhub.io/api/news?id=b5c5a4c1f5342a8db74c7b2150105d48fc0e37dc2df68bd10fbb84b183141f9f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751191260,
      "headline": "Calamos Long/Short Equity & Dynamic Income Trust Q1 2025 Commentary",
      "id": 135631618,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1154731469/image_1154731469.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "For the quarter ending March 31, 2025, Calamos Long/Short Equity & Dynamic Income Trustâs total return was 1.69% on NAV and 6.82% on market price. Read more here.",
      "url": "https://finnhub.io/api/news?id=b5c5a4c1f5342a8db74c7b2150105d48fc0e37dc2df68bd10fbb84b183141f9f"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For July 2025",
    "summary": "Best Dividend Aristocrats For July 2025",
    "url": "https://finnhub.io/api/news?id=0b91450584c711e2485a33bfe300de3807c5ee9005c10f315f854c4ead198f45",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751181558,
      "headline": "Best Dividend Aristocrats For July 2025",
      "id": 135631077,
      "image": "",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0b91450584c711e2485a33bfe300de3807c5ee9005c10f315f854c4ead198f45"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic: Margin Inflection With Diabetes Spin - Key Drivers",
    "summary": "Medtronic's margin inflection from the Diabetes spin-off and strong innovation pipeline support major upside. Find out why MDT stock is a strong buy.",
    "url": "https://finnhub.io/api/news?id=e9014398ef628bcab4bcdd6e3cc39a8d449d69a0c0f5f1e6de283a51d8c176ed",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751180131,
      "headline": "Medtronic: Margin Inflection With Diabetes Spin - Key Drivers",
      "id": 135630985,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/508450420/image_508450420.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "Medtronic's margin inflection from the Diabetes spin-off and strong innovation pipeline support major upside. Find out why MDT stock is a strong buy.",
      "url": "https://finnhub.io/api/news?id=e9014398ef628bcab4bcdd6e3cc39a8d449d69a0c0f5f1e6de283a51d8c176ed"
    }
  }
]